Heart Involvement in Children and Adults with Cystic Fibrosis: Correlation with Pulmonary Indexes and Inflammation Markers

Heart Lung and Circulation

Volumn 24, Issue 10, 2015, Pages 1002-1010

  Giacchi, Valentina ^a   Rotolo, Novella ^a   Amato, Barbara ^a   Di Dio, Giovanna ^a   Betta, Pasqua ^a   La Rosa, Mario ^a   Leonardi, Salvatore ^a   Sciacca, Pietro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cardiac impairment; Cystic fibrosis; Flogosis; Lung function; Pulmonary hypertension

Indexed keywords

C REACTIVE PROTEIN; HIGHLY SENSITIVE C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HEART EJECTION FRACTION; HUMAN; INFLAMMATION; LUNG ARTERY PRESSURE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; YOUNG ADULT; AGE; ARTERIAL PRESSURE; CASE CONTROL STUDY; COLOR DOPPLER ECHOCARDIOGRAPHY; COMPLICATION; CROSS-SECTIONAL STUDY; ECHOGRAPHY; HEART STROKE VOLUME; METABOLISM; PATHOPHYSIOLOGY; PULMONARY ARTERY;

ADOLESCENT; ADULT; AGE FACTORS; ARTERIAL PRESSURE; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PULMONARY ARTERY; STROKE VOLUME; YOUNG ADULT;

EID: 84942196561     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.03.006     Document Type: Article

References (36)

1. Abraham T.P., Dimaano V.L., Liang H.Y. Role of tissue Doppler and strain echocardiography in current clinical practice. Circulation 2007, 116:2597-2609.
2. Hoffman L.R., Ramsey B.W. Cystic Fibrosis Therapeutics. The Road Ahead. CHEST 2013, 143(1):207-213.
3. Ozcelik N., Shell R., Holtzlander M., Cua C. Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients. Pediatr Cardiol 2013, 34:159-164. 10.1007/s00246-012-0407-4.
4. Eidt Rovedder P.M., Ziegler B., Furlan Pinotti A.F., Menna Barreto S.S., de Tarso Roth Dalcin P. Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis. J Bras Pneumol. 2008, 34(2):83-90.
5. Henno P., Maurey C., Danel C., Bonnette P., Souilamas R., Stern M., et al. Pulmonary vascular dysfunction in endstage cystic fibrosis: role of NF-kB and endothelin-1. Eur Respir J 2009, 34:1329-1337. 10.1183/09031936.00186908.
6. Fraser K.L., Tullis D.E., Sasso Z., Hylan R.H., Thornley K.S., Hanly P.J. Pulmonary Hypertension and Cardiac Function in Adult Cystic Fibrosis. Role of Hypoxemia. Chest 1999, 115:1321-1328.
7. Lopez L., Colan S.D., Frommelt P.C., Ensing G.J., Kendall K., Younoszai A.K., et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010, 23(5):465-495.
8. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Eur J Echocardiogr. 2006, 7(2):79-88.
9. Quiñones M.A., Otto C.M., Stoddard M., Waggoner A., Zoghbi W.A. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002, 15(2):167-184.
10. Bright-Thomas R.J., Webb A.K. The heart in cystic fibrosis. J R Soc Med 2002, 95(Suppl. 41):2-10.
11. Manika K., Pitsiou G.G., Boutou A.K., Tsaoussis V., Chavouzis N., Antoniou M., et al. The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis:A Case Control Study. Pulmonary Medicine 2012, 6. Article ID 252345. 10.1155/2012/252345.
12. Bright-Thomas R.J., Ray S.G., Webb A.K. Pulmonary artery pressure in cystic fibrosis adults: Characteristics, clinical correlates and long-term follow-up. Journal of Cystic Fibrosis 2012, 11:532-538.
13. Baño-Rodrigo A., Salcedo-Posadas A., Villa-Asensi J.R., Tamariz-Martel A., Lopez-Neyra A., Blanco-Iglesias E. Right ventricular dysfunction in adolescents with mild cystic fibrosis. Journal of Cystic Fibrosis 2012, 11:274-280.
14. Burghuber O.C., Salzer-Muhar U., Gotz M. Right ventricular contractility is preserved in patients with cystic fibrosis and pulmonary artery hypertension. Scand J Gastroenterol Suppl 1988, 143:93-98.
15. Florea V.G., Florea N.D., Sharma R., Coats A.J., Gibson D.G., Hodson M.E., et al. Right ventricular dysfunction in adult severe cystic fibrosis. Chest 2000, 118(4):1063-1068.
16. Matthay R.A., Berger H.J., Loke J., Dolan T.F., Fagenholz S.A., Gottschalk A., et al. Right and left ventricular performance in ambulatory young adults with cystic fibrosis. Br Heart J 1980, 43(4):474-480.
17. Schenk P., Globits S., Koller J., Brunner C., Artemiou O., Klepetko W., et al. Accuracy of echocardiographic right ventricular parameters in patients with different end-stage lung diseases prior to lung transplantation. J Heart Lung Transplant 2000, 19(2):145-154.
18. Kaul S., Tei C., Hopkins J.M., Shah P.M. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 1984, 107(3):526-531.
19. Ueti O.M., Camargo E.E., Ueti A.A., Lima-Filho E.C., Nogueira E.A. Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography. Heart 2002, 88(3):244-248.
20. Sellers Z.M., Kovacs A., Weinheimer C.J., Best P.M. Left ventricular and aortic dysfunction in cystic fibrosis mice. Journal of Cystic Fibrosis 2013, 12:517-524.
21. Panidis I.P., Ren J.F., Holsclaw D.S., Kotler M.N., Mintz G.S., Ross J. Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography. J Am Coll Cardiol 1985, 6:701-706.
22. Matthay R.A., Berger H.J., Loke J., Dolan T.F., Fagenholz S.A., Gottschalk A., et al. Right and left ventricular performance in ambulatory young adults with cystic fibrosis. Br Heart J 1980, 43:474-480.
23. Jacobstein M.D., Hirschfeld S.S., Winnie G., Doershuk C., Liebman J. Ventricular interdependence in severe cystic fibrosis. A two-dimensional echocardiographic study. Chest. 1981, 80(4 Oct):399-404.
24. Goldring R.M., Fishman A.P., Turino G.M., Cohen H.I., Denning C.R., Anderson D.H. Pulmonary hypertension and cor pulmonale in cystic fibrosis of the pancreas. J Pediatr 1964, 65:501-524.
25. Stern R.C., Borkat G., Hirschfeld S.S., Boat T.F., Matthews L.W., Liebman J., et al. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am J Dis Child 1980, 134:267-272.
26. Siassi B., Moss A.J., Dooley R.R. Clinical recognition of cor pulmonale in cystic fibrosis. J Pediatr 1971, 78:794-805.
27. Sellers Z.M., De Arcangelis V., Xiang Y., Best P.M. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate. J Physiol 2010, 588(Pt 13):2417-2429.
28. Hull J.H., Garrod R., Ho T.B., Knight R.K., Cockcroft J.R., Shale D.J., et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J 2009, 34:1322-1328.
29. Vlachopoulos C., Dima I., Aznaouridis K., Vasiliadou C., Ioakeimidis N., Aggeli C., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005, 112:2193-2200.
30. Hull J.H., Garrod R., Ho T.B., Knight R.K., Cockcroft J.R., Shale D.J., et al. Dynamic vascular changes following intravenous antibiotics in patients with cystic fibrosis. Journal of Cystic Fibrosis 2013, 12:125-129.
31. Nixon L.S., Yung B., Bell S.C., Elborn J.S., Shale D.J. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998, 157:1764-1769.
32. Ionescu A.A., Nixon L.S., Evans W.D., Stone M.D., Lewis-Jenkins V., Chatham K., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:789-794.
33. Bell S.C., Bowerman A.M., Nixon L.E., Macdonald I.A., Elborn J.S., Shale D.J. Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 2000, 30:553-559.
34. Ionescu A.A., Nixon L.S., Shale D.J. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis. J Cyst Fibros 2004, 3:253-258.
35. McCloskey M., Redmond A.O., Pyper S., McCabe C., Westerterp K.R., Elborn S.J. Total energy expenditure in stable patients with cystic fibrosis. Clin Nutr 2001, 20:235-241.
36. Pike S.E., Prasad S.A., Balfour-Lynn I.M. Effect of intravenous antibiotics on exercise tolerance (3-min step test)) in cystic fibrosis. Pediatr Pulmonol 2001, 32:38-43.